OmniAb Insider Trades Reveal Liquidity Strategy Amid Fast‑Track Oncology Milestones
Insider trading at OmniAb shows disciplined liquidity and tax planning, yet confidence in its Fast‑Track antibody pipeline; investors weigh valuation discount against regulatory milestones.
4 minutes to read